Nair Vinay’s Immunogen Inc IMGN Stock Holding History

Nair Vinay’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-31,277	Closed	-$280K	–	359
2015 Q1	$280K	Buy	+31,277	New	+$227K	0.2%	214

Other funds holding IMGN

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nair Vinay's IMGN Position: Q2 2015 in Review

Nair Vinay sold out of Immunogen Inc (IMGN) in Q2 2015, closing a stake of 31,277 shares — an estimated $280K sold.

Nair Vinay first reported a position in IMGN in Q1 2015 and held it in 1 quarter. The position peaked at $280K in Q1 2015. 140 funds tracked by Wall St. Rank hold IMGN as of Q2 2015.

Nair Vinay reported no remaining Immunogen Inc position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 31,277 Immunogen Inc shares in Q2 2015, an estimated $280K.
Nair Vinay first reported a position in Immunogen Inc in Q1 2015 and held it in 1 quarter.
Nair Vinay's Immunogen Inc position peaked at $280K in Q1 2015.
140 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.